Figure 5 | Scientific Reports

Figure 5

From: Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals

Figure 5The alternative text for this image may have been generated using AI.

AmB-NA formulation demonstrated strong antifungal activity against fungal pathogen: (A) Representative time–kill curve plot for C. albicans in the presence of Fungizone, AmBisome or AmB-NA at 4 × MIC. Wells containing no antibiotic were taken as control. Assays were performed in triplicate. Each result is representative of at least three separate experiments. Values represent mean ± SD.

Back to article page